Literature DB >> 22511324

Contrast-enhanced ultrasound diagnosis of splenic artery steal syndrome after orthotopic liver transplantation.

Xian-Sheng Zhu1, Yun-Hua Gao, Sha-Sha Wang, Qi Cheng, Yin Ling, Li Fan, Feng Huo, Miao-Shui Pu, Peng Li.   

Abstract

The aim of this study was to investigate the use of contrast-enhanced ultrasound (CEUS) for the detection of splenic artery steal syndrome (SASS) after orthotopic liver transplantation (OLT). Two hundred forty-seven patients underwent OLT. Blood tests and color Doppler flow imaging (CDFI) were performed at various time points after the operation. CEUS and celiac angiography were used for patients suspected of having SASS. If the diagnosis of SASS was confirmed, splenic artery embolization was performed to enhance hepatic artery flow. CEUS and angiography were performed for the assessment of postinterventional clinical outcomes. Three of the 247 patients died postoperatively, and 8 patients were suspected of having SASS because of elevated liver enzyme levels and slim or undetectable hepatic artery blood signals by CDFI at various points after the operation. In these 8 patients, CEUS showed a delayed and weak contrast-enhanced blood signal in the hepatic artery associated with a rapid and intense enhancement of the portal vein blood. No narrowing of the hyperintense signal was observed in the hepatic artery by CEUS. The 8 diagnoses of SASS were proven by celiac angiography, which showed delayed perfusion of the hepatic artery and rapid filling of the splenic artery. Immediately after the interventional procedure, CEUS demonstrated a significantly enlarged hyperintense blood signal in the hepatic artery. In conclusion, approximately 3.27% of SASS cases occur after OLT. SASS can be identified as a sluggish and weak hyperintense blood signal in the hepatic artery without the narrowing and interruption of the hypointense signal in CEUS imaging. CEUS is an effective imaging modality for the detection of SASS after OLT.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511324     DOI: 10.1002/lt.23453

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

Review 1.  Contrast-enhanced ultrasound applications in liver transplant imaging.

Authors:  Giuseppe Como; Luca Montaldo; Umberto Baccarani; Dario Lorenzin; Chiara Zuiani; Rossano Girometti
Journal:  Abdom Radiol (NY)       Date:  2021-01

2.  Impact of contrast-enhanced ultrasound in the study of hepatic artery hypoperfusion shortly after liver transplantation: contribution to the diagnosis of artery steal syndrome.

Authors:  Angeles García-Criado; Rosa Gilabert; Luis Bianchi; Ramón Vilana; Marta Burrel; Marta Barrufet; Rafael Oliveira; Juan Carlos García-Valdecasas; Concepción Brú
Journal:  Eur Radiol       Date:  2014-08-12       Impact factor: 5.315

3.  New strategies for prevention and treatment of splenic artery steal syndrome after liver transplantation.

Authors:  Ji-Yong Song; Bing-Yi Shi; Zhi-Dong Zhu; De-Hua Zheng; Gang Li; Li-Kui Feng; Lin Zhou; Tian-Tian Wu; Guo-Sheng Du
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Minimally invasive endovascular and biliary treatments of children with acute hepatic artery thrombosis following liver transplantation.

Authors:  Roberto Miraglia; Luigi Maruzzelli; Settimo Caruso; Gianluca Marrone; Kelvin Cortis; Marco Spada; Angelo Luca
Journal:  Pediatr Radiol       Date:  2014-01

Review 5.  Application of contrast-enhanced ultrasound after liver transplantation: Current status and perspectives.

Authors:  Jie Ren; Tao Wu; Bo-Wen Zheng; Ying-Yi Tan; Rong-Qin Zheng; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.

Authors:  Wendy Rogers; Matthew P Robertson; Angela Ballantyne; Brette Blakely; Ruby Catsanos; Robyn Clay-Williams; Maria Fiatarone Singh
Journal:  BMJ Open       Date:  2019-02-05       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.